MedTrace Logo

Use of suPAR Algorithm for the ED Decision Making

NCT04402281 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2022-02-11

No results posted yet for this study

Summary

Will the use of a clinical decision algorithm in the ED improve discharge or admission decisions.

Conditions

  • Critical Illness

Interventions

DIAGNOSTIC_TEST

suPAR algoritm

All medical patients attending to the ED and who will have blood drawn for routine examination will be part of the study. In patients with low suPAR (green group, suPAR below 3 ng/ml) and in patients with high suPAR (red group, suPAR \> 6 ng/mL) the Intervention will be carried out

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Maaret Castrén, Docent · Professor

Eligibility

Min Age
18 Years
Max Age
104 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-11
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04402281 on ClinicalTrials.gov